SBWire

Personal experience from a woman who struggled with weight loss is now helping millions of people reduce tummy fat. The free information is available on a website that targets people who want accurate resource material that works. Jenny, the website’s owner, endured the emotional and physical pain of weight gain for years. She decided to embark on efficient weight loss strategies after giving birth to her second child.

Friday December 21th is National Ugly Christmas Sweater Day, a day to celebrate the fine art of woven and embellished holiday tackiness. Now, thanks to the Sweater-izer app, you can use your mobile phone to take the unfashionable party online where, incidentally, it is a lot less itchy and there is a much larger audience.

GlobalData's clinical trial report, "Respiratory Insufficiency Global Clinical Trials Review, H2, 2012" provides data on the Respiratory Insufficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Respiratory Insufficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Respiratory Insufficiency. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's clinical trial report, "Emphysema Global Clinical Trials Review, H2, 2012" provides data on the Emphysema clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Emphysema. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Emphysema. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's new report, "Mexico Patient Monitoring Market Outlook to 2018 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors and Others" provides key market data on the Mexico Patient Monitoring market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories - Fetal Monitors, Micro-Electromechanical Systems, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Patient Monitoring Accessories and Remote Patient Monitoring. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

Global Markets Direct's, 'Streptococcus Pneumoniae (Pneumococcus) Infections - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Streptococcus Pneumoniae (Pneumococcus) Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Streptococcus Pneumoniae (Pneumococcus) Infections. Streptococcus Pneumoniae (Pneumococcus) Infections - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Salivary Gland Cancer - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Salivary Gland Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Salivary Gland Cancer. Salivary Gland Cancer - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

In the present-day context, commercialism has redefined every aspect of our life. It is unfortunate that even the medical field seems to have aligned with commercialism because some of the medical institutions are being run with an eye on profits. Competition has become stiff even in the medical field and this is a paradoxical situation in this service-oriented industry. Because of the competition that prevails and the profit motive some of these medical institutions have, the real medical care that should be available to those who need it has been relegated. People may think that competition may bring good for them as well as for the industry but, it has produced exactly the opposite results. This clearly means that those institutions that operate with a motive to earn profits are not run by the spirit that is expected of the medical field. But, the Orthopedic and Sports Medicine Institute in Fort Worth Metroplex of Dallas says that they are like an oasis because their goal is not to run after profits but to heal the orthopedic problems including the orthopedic shoulder pain of their patients. According to them, patients will certainly rate the quality of the orthopedic as well as the sports therapy they receive from the institute as the best because this institution always strives to provide the most comfortable environment and experience to every patient. It is the endeavor of the institute to make the healing process stress-free for their patients.

Global Market Direct's pharmaceuticals report, "Conkwest, Inc. - Product Pipeline Review - 2012" provides data on the Conkwest, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Market Direct's pharmaceuticals report, "TAU Therapeutics, LLC - Product Pipeline Review - 2012" provides data on the TAU Therapeutics, LLC's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Markets Direct's, 'Axial Spondyloarthritis - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Axial Spondyloarthritis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Axial Spondyloarthritis. Axial Spondyloarthritis - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Male Infertility - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Male Infertility, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Male Infertility. Male Infertility - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

President Cristina Fernandez de Kirchner will probably regard her landslide victory in Argentina's October 2011 elections as an expression of approval for her handling of economic policy rather than as an occasion to implement the structural reforms needed to reverse macroeconomic imbalances that BMI sees increasingly fostering internal security weaknesses.

BMI View: We believe despite a temporary cash flow crisis for private hospitals in Jordan they will still have profited greatly from the influx of Libyan patients since the end of the civil war in 2011. It is our view that hospitals are likely to be reimbursed for all the procedures performed, possibly excluding elective cosmetic surgery. Therefore, they are likely to make a profit now the political wrangling about who is footing the bill is over. This is especially important as the country's economic woes mean the government is in a poor fiscal position to support the sector if its debts remain unpaid.

The Montenegrin insurance segment recorded growth with a CAGR of 6.2% during the review period. Government promotional measures such as subsidies on insurance premiums for agriculture output, an improvement in loss ratio and increased awareness for insurance products supported such growth. A rise in foreign investments increased competition in the market. During the last decade Montenegro's insurance segment has recorded uneven economic growth. The industry was not exposed to the financial crisis of 2008 and 2011 due to its relative underdevelopment.

A strong brand can drive a business to success and can even become its most valuable asset. Brands were originally developed as labels of ownership, as denoted by a name and a symbol, but they have come to represent much more. Building a successful brand requires, engaging and establishing an emotional connection to achieve advocacy. While the design and creativity of the brand is important, the brand is more about the total individuality or distinctiveness of the firm. Reputation is the key, and is formed in consumer's mind based on experiences and the description of the company by others. Brand building and promotion are linked up with the people who work for the firm and effectively embody the brand. Long-term commitment is required to serve the unbanked market effectively. Time must be devoted to understand the characteristics, diversity and the financial services needs of the unbanked, and a mutually beneficial banking relationship, based on trust, has to be established.

An optimized phone system network provides the capacity to support exactly what is needed by the business in terms of incoming and outgoing voice calls, voicemail, IVR, call management, conferencing (on VoIP phones) and other standard features, saving costs and removing redundancy in the process.

GlobalData's new report, "Belgium Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery" provides key market data on the Belgium Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories - Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

GlobalData's clinical trial report, "Subarachnoid Hemorrhage Global Clinical Trials Review, H2, 2012" provides data on the Subarachnoid Hemorrhage clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Subarachnoid Hemorrhage. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Subarachnoid Hemorrhage. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

BMI View: We are maintaining our 6.9% growth forecast for Indonesia's construction sector in 2012. Although construction activity in Q212 remained as strong as in Q112, we do not see significant scope for Indonesia to outperform in H212, due to challenging global economic conditions. Looking beyond 2012, we are cautiously optimistic about construction and have slightly revised up our real growth forecasts for the sector to 7.2% in 2013 (from a previous forecast of 7.0%). That said, several downside factors (i.e. deepening deficit, bottlenecks in project execution and the 2014 presidential elections) continue to prevent the sector from maximising its growth potential.

Although the details vary from quarter to quarter, newsflow from Canada's insurance sector continues, in late-2012, to highlight its strength and dynamism. In both the non-life and the life segment, the main players have scale, access to capital (even if they are mutuals), financial strength, well recognised brands, and clearly enunciated strategies for growth. In each case, business is developing as a result of at least one of the following factors: increased numbers of policies and policy-holders; firming prices; changes to distribution arrangements; product innovation; acquisition of rival businesses in Canada, and expansion in markets overseas in ways that exploit the competitive advantage of the company in question. As has been the case for a while, a major challenge comes from pervasive low interest rates and, for some companies, the general volatility of equity markets.

Global Markets Direct's, 'Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections. Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Chronic Lymphocytic Leukemia (CLL), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chronic Lymphocytic Leukemia (CLL). Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Comprising of textual analysis and data tables, this in-depth and exclusive country report from Canadean provides a comprehensive view of the cider industry structure including analysis and profiles on trade mark owners and local operators. Brand volumes and market share are given by price segment, alcoholic strength and type (e.g. apple, pear, flavored). Consumption volumes are provided by pack mix (type, material, refill ability, pack size) and distribution channel (on- and off-premise). Other information includes market valuation/pricing data and new products are identified. All supported by market commentary.